Patents by Inventor Edgar Voss

Edgar Voss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aniline derivatives, their manufacture and use as pharmaceutical agents
    Publication number: 20040254217
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: April 28, 2004
    Publication date: December 16, 2004
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Ulrike Reiff, Matthias Rueth, Edgar Voss
  • 2-(2,6-Dichlorophenyl)-Diarylimidazoles
    Publication number: 20040214874
    Abstract: 1
    Type: Application
    Filed: May 18, 2004
    Publication date: October 28, 2004
    Inventors: Michael Brandt, George Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • Oxazole derivatives
    Publication number: 20040209933
    Abstract: The present invention 1 includes compounds of formula (I), 1
    Type: Application
    Filed: March 25, 2004
    Publication date: October 21, 2004
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Bernhard Goller, Matthias Rueth, Edgar Voss
  • 2-(2,6-dichlorophenyl)-diarylimidazoles
    Patent number: 6790852
    Abstract: The invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and related diseases.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: September 14, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Brandt, Georg Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • 2-(2,6-dichlorophenyl)-diarylimidazoles
    Publication number: 20030199691
    Abstract: 1
    Type: Application
    Filed: April 7, 2003
    Publication date: October 23, 2003
    Inventors: Michael Brandt, Georg Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • 2,2-Dichloroalkanecarboxylic acids, processes for their production and pharmaceutical agents containing these
    Patent number: 5968982
    Abstract: Pharmaceutical agents for treating diabetus mellitus which contain a compound of formula I ##STR1## as the active substance, in which A, B, A' and W have the meanings stated in the claims, new compounds of formula I as well as processes for their production.
    Type: Grant
    Filed: July 8, 1997
    Date of Patent: October 19, 1999
    Assignee: Roche Diagnostics GmbH
    Inventors: Edgar Voss, Johannes Pill, Peter Freund
  • Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
    Patent number: 5955452
    Abstract: The present invention concerns new lipid derivatives of phosphonocarboxylic acids of the general formula I, ##STR1## in which the meaning of the symbols is elucidated in the description, tautomers thereof and their physiologically tolerated salts of inorganic and organic bases as well as processes for the production thereof and pharmaceutical agents containing these compounds.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: September 21, 1999
    Assignee: Roche Diagnostics GmbH
    Inventors: Harald Zilch, Dieter Herrmann, Hans-George Opitz, Gerd Zimmermann, Edgar Voss
  • Bishispidine compounds, processes for their production and pharmaceutical agents containing these compounds
    Patent number: 5731344
    Abstract: The invention concerns new bishipidine derivatives, processes for their production and pharmaceutical agents containing these compounds. The new methylene-bishispidine derivatives can be used for the prophylaxis and therapy of late diabetic damage as well as for the prophylaxis and therapy of atherosclerosis and arteriosclerosis.
    Type: Grant
    Filed: October 18, 1996
    Date of Patent: March 24, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Edgar Voss, Rudolf Reiter, Claus Kilpert